Wang Q, Yang H
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39459035
PMC: 11510623.
DOI: 10.3390/ph17101396.
Carson M, Xu P, Gildea J, Marino C, Felder R
Methods Mol Biol. 2024; 2823:95-108.
PMID: 39052216
DOI: 10.1007/978-1-0716-3922-1_7.
Cai W, Rong D, Ding J, Zhang X, Wang Y, Fang Y
Cancer Cell Int. 2024; 24(1):249.
PMID: 39020371
PMC: 11256575.
DOI: 10.1186/s12935-024-03443-w.
Karbon G, Schuler F, Braun V, Eichin F, Haschka M, Drach M
EMBO Rep. 2024; 25(6):2743-2772.
PMID: 38806674
PMC: 11169569.
DOI: 10.1038/s44319-024-00160-3.
Xia F, Yang H, Wu H, Zhao B
Sci Rep. 2024; 14(1):8452.
PMID: 38605119
PMC: 11009294.
DOI: 10.1038/s41598-024-59038-y.
The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy.
Pathania A, Chava H, Balusu R, Pasupulati A, Coulter D, Challagundla K
Mol Ther Oncol. 2024; 32(2):200785.
PMID: 38595981
PMC: 10973673.
DOI: 10.1016/j.omton.2024.200785.
Engineering small-molecule and protein drugs for targeting bone tumors.
Wang Y, Wang C, Xia M, Tian Z, Zhou J, Berger J
Mol Ther. 2024; 32(5):1219-1237.
PMID: 38449313
PMC: 11081876.
DOI: 10.1016/j.ymthe.2024.03.001.
Distinct characteristics of the DNA damage response in mammalian oocytes.
Leem J, Lee C, Choi D, Oh J
Exp Mol Med. 2024; 56(2):319-328.
PMID: 38355825
PMC: 10907590.
DOI: 10.1038/s12276-024-01178-2.
The yin and yang of chromosomal instability in prostate cancer.
Carceles-Cordon M, Orme J, Domingo-Domenech J, Rodriguez-Bravo V
Nat Rev Urol. 2024; 21(6):357-372.
PMID: 38307951
PMC: 11156566.
DOI: 10.1038/s41585-023-00845-9.
TTK/MPS1 inhibitor OSU-13 targets the mitotic checkpoint and is a potential therapeutic strategy for myeloma.
Longo L, Hughes T, McNeil-Laidley B, Cottini F, Hilinski G, Merritt E
Haematologica. 2023; 109(2):578-590.
PMID: 37496433
PMC: 10828771.
DOI: 10.3324/haematol.2023.282838.
Pleiotropy of autism-associated chromatin regulators.
Lasser M, Sun N, Xu Y, Wang S, Drake S, Law K
Development. 2023; 150(14).
PMID: 37366052
PMC: 10399978.
DOI: 10.1242/dev.201515.
Chromosomal instability and its effect on cell lines.
He Z, Wilson A, Rich F, Kenwright D, Stevens A, Low Y
Cancer Rep (Hoboken). 2023; 6(6):e1822.
PMID: 37095005
PMC: 10242654.
DOI: 10.1002/cnr2.1822.
The critical role of circular RNAs in drug resistance in gastrointestinal cancers.
Tehrani S, Esmaeili F, Shirzad M, Goodarzi G, Yousefi T, Maniati M
Med Oncol. 2023; 40(4):116.
PMID: 36917431
DOI: 10.1007/s12032-023-01980-4.
Polyploid giant cancer cells and cancer progression.
Zhou X, Zhou M, Zheng M, Tian S, Yang X, Ning Y
Front Cell Dev Biol. 2022; 10:1017588.
PMID: 36274852
PMC: 9581214.
DOI: 10.3389/fcell.2022.1017588.
SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway.
Yang J, Huang Y, Song M, Pan Q, Zhao J, He J
Int J Biol Sci. 2022; 18(14):5241-5259.
PMID: 36147467
PMC: 9461674.
DOI: 10.7150/ijbs.71694.
and gene expression as potential malignant tumor markers.
Liu H, Zhou Q, Xu X, Du Y, Wu J
Ann Transl Med. 2022; 10(10):586.
PMID: 35722431
PMC: 9201116.
DOI: 10.21037/atm-22-1112.
Phosphorylation of MAD2 at Ser195 Promotes Spindle Checkpoint Defects and Sensitizes Cancer Cells to Radiotherapy in ATM Deficient Cells.
Wang Y, Yu T, Han Y, He Y, Song Y, Guo L
Front Cell Dev Biol. 2022; 10:817831.
PMID: 35309941
PMC: 8924061.
DOI: 10.3389/fcell.2022.817831.
Targeting Cell Cycle Checkpoint Kinases to Overcome Intrinsic Radioresistance in Brain Tumor Cells.
Vlatkovic T, Veldwijk M, Giordano F, Herskind C
Cancers (Basel). 2022; 14(3).
PMID: 35158967
PMC: 8833533.
DOI: 10.3390/cancers14030701.
TORC1 inactivation promotes APC/C-dependent mitotic slippage in yeast and human cells.
Yamada C, Morooka A, Miyazaki S, Nagai M, Mase S, Iemura K
iScience. 2022; 25(2):103675.
PMID: 35141499
PMC: 8814761.
DOI: 10.1016/j.isci.2021.103675.
Bioinformatics Analysis of Prognostic Value of in ccRCC and Pan-Cancer.
Zhang J, Chen X, Wang J, Zhang P, Han X, Zhang Y
Int J Gen Med. 2022; 15:817-836.
PMID: 35125884
PMC: 8807948.
DOI: 10.2147/IJGM.S348859.